Selective anti-malarial minor groove binders

Fraser J. Scott, Abedawn I. Khalaf, Sandra Duffy, Vicky M. Avery, Colin J. Suckling

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A set of 31 DNA minor groove binders (MGBs) with diverse structural features relating to both physical chemical properties and DNA binding sequence preference has been evaluated as potential drugs to treat Plasmodium falciparum infections using a chloroquine sensitive strain (3D7) and a chloroquine resistant strain (Dd2) in comparison with human embryonic kidney (HEK) cells as an indicator of mammalian cell toxicity. MGBs with an alkene link between the two N-terminal building blocks were demonstrated to be most active with IC50 values in the range 30 – 500 nM and therapeutic ratios in the range 10 - > 500. Many active compounds contained a C-alkylthiazole building block. Active compounds with logD7.4 values of approximately 3 or 7 were identified. Importantly the MGBs tested were essentially equally effective against both chloroquine sensitive and resistant strains. The results show that suitably designed MGBs have the potential for development into clinical candidates for antimalarial drugs effective against resistant strains of Plasmodia.
LanguageEnglish
Pages3326-3329
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume26
Early online date13 May 2016
DOIs
Publication statusPublished - 15 Jul 2016

Fingerprint

Chloroquine
Antimalarials
Binders
Plasmodium
Alkenes
Plasmodium falciparum
Inhibitory Concentration 50
Malaria
DNA
Chemical properties
Toxicity
Kidney
Cells
Pharmaceutical Preparations
Therapeutics

Keywords

  • DNA minor groove binder
  • plasmodium falciparum
  • antimalarial drugs

Cite this

Scott, Fraser J. ; Khalaf, Abedawn I. ; Duffy, Sandra ; Avery, Vicky M. ; Suckling, Colin J. / Selective anti-malarial minor groove binders. In: Bioorganic and Medicinal Chemistry Letters. 2016 ; Vol. 26. pp. 3326-3329.
@article{9bd1c1102cbe4043b8a8212cee3580e7,
title = "Selective anti-malarial minor groove binders",
abstract = "A set of 31 DNA minor groove binders (MGBs) with diverse structural features relating to both physical chemical properties and DNA binding sequence preference has been evaluated as potential drugs to treat Plasmodium falciparum infections using a chloroquine sensitive strain (3D7) and a chloroquine resistant strain (Dd2) in comparison with human embryonic kidney (HEK) cells as an indicator of mammalian cell toxicity. MGBs with an alkene link between the two N-terminal building blocks were demonstrated to be most active with IC50 values in the range 30 – 500 nM and therapeutic ratios in the range 10 - > 500. Many active compounds contained a C-alkylthiazole building block. Active compounds with logD7.4 values of approximately 3 or 7 were identified. Importantly the MGBs tested were essentially equally effective against both chloroquine sensitive and resistant strains. The results show that suitably designed MGBs have the potential for development into clinical candidates for antimalarial drugs effective against resistant strains of Plasmodia.",
keywords = "DNA minor groove binder, plasmodium falciparum, antimalarial drugs",
author = "Scott, {Fraser J.} and Khalaf, {Abedawn I.} and Sandra Duffy and Avery, {Vicky M.} and Suckling, {Colin J.}",
year = "2016",
month = "7",
day = "15",
doi = "10.1016/j.bmcl.2016.05.039",
language = "English",
volume = "26",
pages = "3326--3329",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",

}

Selective anti-malarial minor groove binders. / Scott, Fraser J.; Khalaf, Abedawn I.; Duffy, Sandra; Avery, Vicky M.; Suckling, Colin J.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 26, 15.07.2016, p. 3326-3329.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Selective anti-malarial minor groove binders

AU - Scott, Fraser J.

AU - Khalaf, Abedawn I.

AU - Duffy, Sandra

AU - Avery, Vicky M.

AU - Suckling, Colin J.

PY - 2016/7/15

Y1 - 2016/7/15

N2 - A set of 31 DNA minor groove binders (MGBs) with diverse structural features relating to both physical chemical properties and DNA binding sequence preference has been evaluated as potential drugs to treat Plasmodium falciparum infections using a chloroquine sensitive strain (3D7) and a chloroquine resistant strain (Dd2) in comparison with human embryonic kidney (HEK) cells as an indicator of mammalian cell toxicity. MGBs with an alkene link between the two N-terminal building blocks were demonstrated to be most active with IC50 values in the range 30 – 500 nM and therapeutic ratios in the range 10 - > 500. Many active compounds contained a C-alkylthiazole building block. Active compounds with logD7.4 values of approximately 3 or 7 were identified. Importantly the MGBs tested were essentially equally effective against both chloroquine sensitive and resistant strains. The results show that suitably designed MGBs have the potential for development into clinical candidates for antimalarial drugs effective against resistant strains of Plasmodia.

AB - A set of 31 DNA minor groove binders (MGBs) with diverse structural features relating to both physical chemical properties and DNA binding sequence preference has been evaluated as potential drugs to treat Plasmodium falciparum infections using a chloroquine sensitive strain (3D7) and a chloroquine resistant strain (Dd2) in comparison with human embryonic kidney (HEK) cells as an indicator of mammalian cell toxicity. MGBs with an alkene link between the two N-terminal building blocks were demonstrated to be most active with IC50 values in the range 30 – 500 nM and therapeutic ratios in the range 10 - > 500. Many active compounds contained a C-alkylthiazole building block. Active compounds with logD7.4 values of approximately 3 or 7 were identified. Importantly the MGBs tested were essentially equally effective against both chloroquine sensitive and resistant strains. The results show that suitably designed MGBs have the potential for development into clinical candidates for antimalarial drugs effective against resistant strains of Plasmodia.

KW - DNA minor groove binder

KW - plasmodium falciparum

KW - antimalarial drugs

UR - http://www.sciencedirect.com/science/article/pii/S0960894X16305248

U2 - 10.1016/j.bmcl.2016.05.039

DO - 10.1016/j.bmcl.2016.05.039

M3 - Article

VL - 26

SP - 3326

EP - 3329

JO - Bioorganic and Medicinal Chemistry Letters

T2 - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

ER -